First international TNBC conference meeting report

Padmashree Rida; Angela Ogden; Ian O Ellis; Zsuzsanna Varga; Antonio C Wolff; Tiffany A Traina; Christos Hatzis; Julie R Palmer; Christine B Ambrosone; Brian D Lehmann; Rita Nanda; Valerie Montgomery Rice; Otis W Brawley; Mylin A Torres; Emad Rakha; Ritu Aneja

doi:10.1007/s10549-018-4692-3

First international TNBC conference meeting report

Breast Cancer Res Treat. 2018 Jun;169(3):407-412. doi: 10.1007/s10549-018-4692-3. Epub 2018 Feb 8.

Authors

Padmashree Rida^{1

2}, Angela Ogden¹, Ian O Ellis³, Zsuzsanna Varga⁴, Antonio C Wolff⁵, Tiffany A Traina^{6

7}, Christos Hatzis⁸, Julie R Palmer⁹, Christine B Ambrosone¹⁰, Brian D Lehmann¹¹, Rita Nanda¹², Valerie Montgomery Rice¹³, Otis W Brawley¹⁴, Mylin A Torres^{15

16}, Emad Rakha³, Ritu Aneja¹⁷

Affiliations

¹ Department of Biology, Georgia State University, Atlanta, GA, USA.
² Novazoi Theranostics, Rolling Hills Estates, CA, USA.
³ Department of Histopathology, Nottingham City Hospital NHS Trust, Nottingham University, Nottingham, UK.
⁴ Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
⁵ The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
⁶ Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Weill Cornell Medicine, New York, NY, USA.
⁸ Department of Medicine, Breast Medical Oncology, Yale School of Medicine, Yale University, New Haven, CT, USA.
⁹ Slone Epidemiology Center, Boston University, Boston, MA, USA.
¹⁰ Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
¹¹ Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.
¹² Section of Hematology-Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA.
¹³ Morehouse School of Medicine, Atlanta, GA, USA.
¹⁴ American Cancer Society, Atlanta, GA, USA.
¹⁵ Department of Radiation Oncology, Emory University, Atlanta, GA, USA.
¹⁶ Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
¹⁷ Department of Biology, Georgia State University, Atlanta, GA, USA. raneja@gsu.edu.

Abstract

Recently, Georgia State University's Centennial Hall was the premier location for the 2017 International Conference on Triple Negative Breast Cancer (TNBC): Illuminating Actionable Biology, which was held from Sept. 18 to 20, 2017, in Atlanta, USA. The conference featured a stellar line-up of domestic and international speakers and diverse participants including TNBC survivors, luminaries in breast cancer research, medical students and fellows, clinicians, translational researchers, epidemiologists, biostatisticians, bioinformaticians, and representatives from the industry. This report distills the burning questions that spiked the event and summarizes key themes, findings, unique opportunities and future directions that emerged from this confluence of thought leaders.

Keywords: Immunotherapy; Molecular subtypes; Racial disparities; Targeted drugs; Triple negative breast cancer.

Publication types

Congress

MeSH terms

Animals
Biomarkers, Tumor
Delivery of Health Care
Female
Healthcare Disparities
Humans
Molecular Targeted Therapy
Risk Factors
Triple Negative Breast Neoplasms / diagnosis*
Triple Negative Breast Neoplasms / epidemiology
Triple Negative Breast Neoplasms / etiology
Triple Negative Breast Neoplasms / therapy*

Substances

Biomarkers, Tumor

Abstract

Publication types

MeSH terms

Substances

Grants and funding